476 related articles for article (PubMed ID: 16514504)
1. Attention deficit hyperactivity disorder, tics and Tourette's syndrome: the relationship and treatment implications. A commentary.
Robertson MM
Eur Child Adolesc Psychiatry; 2006 Feb; 15(1):1-11. PubMed ID: 16514504
[TBL] [Abstract][Full Text] [Related]
2. Concomitant use of atomoxetine and OROS-methylphenidate in a 10-year-old child suffering from attention-deficit/hyperactivity disorder with comorbid bipolar disorder and Tourette syndrome.
Jaworowski S; Benarroch F; Gross-Tsur V
J Child Adolesc Psychopharmacol; 2006 Jun; 16(3):365-70. PubMed ID: 16768644
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders.
Bloch MH; Panza KE; Landeros-Weisenberger A; Leckman JF
J Am Acad Child Adolesc Psychiatry; 2009 Sep; 48(9):884-893. PubMed ID: 19625978
[TBL] [Abstract][Full Text] [Related]
4. Tic exacerbation and precipitation during atomoxetine treatment in two children with attention-deficit hyperactivity disorder.
Párraga HC; Párraga MI; Harris DK
Int J Psychiatry Med; 2007; 37(4):415-24. PubMed ID: 18441629
[TBL] [Abstract][Full Text] [Related]
5. Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome.
Spencer TJ; Sallee FR; Gilbert DL; Dunn DW; McCracken JT; Coffey BJ; Budman CL; Ricardi RK; Leonard HL; Allen AJ; Milton DR; Feldman PD; Kelsey DK; Geller DA; Linder SL; Lewis DW; Winner PK; Kurlan RM; Mintz M
J Atten Disord; 2008 Jan; 11(4):470-81. PubMed ID: 17934184
[TBL] [Abstract][Full Text] [Related]
6. Tourette Syndrome and comorbid ADHD: current pharmacological treatment options.
Rizzo R; Gulisano M; Calì PV; Curatolo P
Eur J Paediatr Neurol; 2013 Sep; 17(5):421-8. PubMed ID: 23473832
[TBL] [Abstract][Full Text] [Related]
7. Psychopharmacology for the clinician: management of comorbid Tourette syndrome and attention-deficit/hyperactivity disorder: are psychostimulants an option?
Pringsheim T
J Psychiatry Neurosci; 2012 Nov; 37(6):432. PubMed ID: 23092593
[No Abstract] [Full Text] [Related]
8. Switching from neurostimulant therapy to atomoxetine in children and adolescents with attention-deficit hyperactivity disorder : clinical approaches and review of current available evidence.
Prasad S; Steer C
Paediatr Drugs; 2008; 10(1):39-47. PubMed ID: 18162007
[TBL] [Abstract][Full Text] [Related]
9. Bupropion exacerbates tics in children with attention-deficit hyperactivity disorder and Tourette's syndrome.
Spencer T; Biederman J; Steingard R; Wilens T
J Am Acad Child Adolesc Psychiatry; 1993 Jan; 32(1):211-4. PubMed ID: 8428875
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy patterns and predictors of ADHD in commercially insured and Medicaid populations.
Molife C; Bernauer MJ; Farr AM; Haynes VS; Kelsey D
Postgrad Med; 2012 Sep; 124(5):7-22. PubMed ID: 23095422
[TBL] [Abstract][Full Text] [Related]
11. The relationship between tourette syndrome, attention deficit hyperactivity disorder, and stimulant medication: a critical review.
Erenberg G
Semin Pediatr Neurol; 2005 Dec; 12(4):217-21. PubMed ID: 16780292
[TBL] [Abstract][Full Text] [Related]
12. Effects of stimulants and atomoxetine on cortisol levels in children with ADHD.
Isaksson J; Hogmark Å; Nilsson KW; Lindblad F
Psychiatry Res; 2013 Oct; 209(3):740-1. PubMed ID: 23850434
[TBL] [Abstract][Full Text] [Related]
13. Effects of atomoxetine and methylphenidate on sleep in children with ADHD.
Sangal RB; Owens J; Allen AJ; Sutton V; Schuh K; Kelsey D
Sleep; 2006 Dec; 29(12):1573-85. PubMed ID: 17252888
[TBL] [Abstract][Full Text] [Related]
14. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
15. Update on drugs for hyperactivity in childhood.
Drug Ther Bull; 2007 May; 45(5):37-40. PubMed ID: 17536494
[TBL] [Abstract][Full Text] [Related]
16. Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?
Niederhofer H
Psychiatr Danub; 2009 Sep; 21(3):330. PubMed ID: 19794351
[No Abstract] [Full Text] [Related]
17. Prefrontal grey and white matter neurometabolite changes after atomoxetine and methylphenidate in children with attention deficit/hyperactivity disorder: a (1)H magnetic resonance spectroscopy study.
Husarova V; Bittsansky M; Ondrejka I; Dobrota D
Psychiatry Res; 2014 Apr; 222(1-2):75-83. PubMed ID: 24679996
[TBL] [Abstract][Full Text] [Related]
18. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
Schulz KP; Fan J; Bédard AC; Clerkin SM; Ivanov I; Tang CY; Halperin JM; Newcorn JH
Arch Gen Psychiatry; 2012 Sep; 69(9):952-61. PubMed ID: 22945622
[TBL] [Abstract][Full Text] [Related]
19. Tourette's syndrome: are stimulants safe?
Kurlan R
Curr Neurol Neurosci Rep; 2003 Jul; 3(4):285-8. PubMed ID: 12930697
[TBL] [Abstract][Full Text] [Related]
20. A head-to-head randomized clinical trial of methylphenidate and atomoxetine treatment for executive function in adults with attention-deficit hyperactivity disorder.
Ni HC; Shang CY; Gau SS; Lin YJ; Huang HC; Yang LK
Int J Neuropsychopharmacol; 2013 Oct; 16(9):1959-73. PubMed ID: 23672818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]